English | Español
Patient Daily | Feb 23, 2026

Study finds no link between ketamine’s psychedelic effects and sobriety outcomes
Patient Daily | Feb 23, 2026

OVACell advances T cell therapy targeting viral sequences for ovarian cancer
Patient Daily | Feb 23, 2026

AI tool aims to predict serious complications after stem cell transplants
Patient Daily | Feb 23, 2026

Applying scientific methods can help life science startups avoid common commercial pitfalls
Patient Daily | Feb 23, 2026

Podcast explores new strategies for obesity treatment beyond current GLP-1 therapies
Patient Daily | Feb 23, 2026

Novartis partners with Unnatural Products on peptide therapies in deal worth up to $1.7 billion
Patient Daily | Feb 23, 2026

FDA reduces clinical trial requirement for new drug approvals
Patient Daily | Feb 23, 2026

Johnson & Johnson announces $1B cell therapy plant investment in Pennsylvania

Trending
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+ Pharmaceuticals
Patient Daily | Apr 1, 2026

Biopharma mergers and acquisitions reach $46.8 billion in first quarter of 2026
+ Regulatory
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'